Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6930119 | BRAINTREE | Liquid pharmaceutical composition |
Jul, 2022
(1 year, 9 months ago) |
Market Authorisation Date: 25 May, 2004
Treatment: NA
Dosage: SOLUTION;ORAL